hitoff 0,088 mg tabletki
adamed pharma s.a. - pramipexoli dihydrochloridum monohydricum - tabletki - 0,088 mg
hitoff 0,18 mg tabletki
adamed pharma s.a. - pramipexoli dihydrochloridum monohydricum - tabletki - 0,18 mg
hitoff 0,35 mg tabletki
adamed pharma s.a. - pramipexoli dihydrochloridum monohydricum - tabletki - 0,35 mg
tritace 2,5 comb 2,5 mg + 12,5 mg tabletki
sanofi-aventis deutschland gmbh - ramiprilum + hydrochlorothiazidum - tabletki - 2,5 mg + 12,5 mg
hitoff 0,7 mg tabletki
adamed pharma s.a. - pramipexoli dihydrochloridum monohydricum - tabletki - 0,7 mg
metamizole kalceks 500 mg/ml roztwór do wstrzykiwań
as kalceks - metamizolum natricum monohydricum - roztwór do wstrzykiwań - 500 mg/ml
sarclisa
sanofi winthrop industrie - isatuximab - szpiczak mnogi - Środki przeciwnowotworowe - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.
ontilyv
bial portela & companhia s.a. - opicapone - choroba parkinsona - leki przeciw chorobie parkinsona - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.
pixalzina 500 mg tabletki powlekane
zentiva, k.s. - metamizolum natricum monohydricum - tabletki powlekane - 500 mg
apidra
sanofi-aventis deutschland gmbh - insulina glulizynowa - cukrzyca - leki stosowane w cukrzycy - leczenie dorosłych, młodzieży i dzieci w wieku sześciu lat lub starszych z cukrzycą, w przypadku których wymagane jest leczenie insuliną.